Clinical Outcome And Toxicity Of Induction Followed By Definitive Concurrent Chemoradiotherapy With Weekly Paclitaxel Plus Carboplatin In Squamous Cell Carcinoma Of Esophagus Unsuitable For Surgery

被引：0
|
作者：
Rastogi, M. [1 ]
Gandhi, A. K. [1 ]
Singh, H. B. [1 ]
Nanda, S. S., Sr. [2 ]
Rath, S. [1 ]
Khurana, R. [1 ]
Hadi, R. [3 ]
Mishra, S. P. [1 ]
Srivastva, A. K. [3 ]
Bharati, A. [1 ]
机构：
[1] Dr Ram Manohar Lohia Inst Med Sci, Dept Radiat Oncol, Lucknow, Uttar Pradesh, India
[2] TMH, Varanasi, Uttar Pradesh, India
[3] Dr Ram Manohar Lohia Inst Med Sci, Lucknow, Uttar Pradesh, India
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3535
引用
收藏
页码：E662 / E663
页数：2
相关论文
共 50 条
  • [31] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma Discussion
    Sugarbaker, David J.
    Molena, Daniela
    Swanson, Scott
    Decamp, Malcolm M.
    Weksler, Benny
    Lerut, Toni
    Chen, Ke-Neng
    Yang, Haoxian
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2719 - +
  • [32] A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus
    Yang, H.
    Fu, J.
    Liu, M.
    Chen, Y.
    Chen, Z.
    Zhu, C.
    Yang, H.
    Fang, W.
    Wang, J.
    Yu, Z.
    Pang, Q.
    Mao, W.
    Zheng, X.
    Xiang, J.
    Yang, H.
    Han, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
    Liu, Shiliang
    Luo, Liling
    Zhao, Lei
    Zhu, Yujia
    Liu, Hui
    Li, Qiaoqiao
    Cai, Ling
    Hu, Yonghong
    Qiu, Bo
    Zhang, Li
    Shen, Jingxian
    Yang, Yadi
    Liu, Mengzhong
    Xi, Mian
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [34] Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck
    Balermpas, P.
    Bauer, C.
    Fraunholz, I.
    Ottinger, A.
    Wagenblast, J.
    Stoever, T.
    Seitz, O.
    Fokas, E.
    Roedel, C.
    Weiss, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (03) : 256 - 262
  • [35] Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
    Shiliang Liu
    Liling Luo
    Lei Zhao
    Yujia Zhu
    Hui Liu
    Qiaoqiao Li
    Ling Cai
    Yonghong Hu
    Bo Qiu
    Li Zhang
    Jingxian Shen
    Yadi Yang
    Mengzhong Liu
    Mian Xi
    Nature Communications, 12
  • [36] Long-term results of definitive chemoradiotherapy for clinical stage I squamous cell carcinoma of the esophagus
    Ito, Y.
    Akatsuka, S.
    Muro, K.
    Kagami, Y.
    Imai, A.
    Sumi, M.
    Mayahara, H.
    Hamaguchi, T.
    Shirao, K.
    Ikeda, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S267 - S267
  • [37] Induction chemotherapy followed by concurrent chemoradiotherapy with/without esophagectomy for locally advanced esophageal squamous cell carcinoma
    Lin, C.
    Hsu, C.
    Cheng, J. C.
    Lee, J.
    Tsai, Y.
    Luo, J.
    Hsu, F.
    Wang, H.
    Lee, Y.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma
    Chen, Guofu
    Sheng, Liming
    Du, Xianghui
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (03) : 505 - 510
  • [39] Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma
    Guofu Chen
    Liming Sheng
    Xianghui Du
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 505 - 510
  • [40] Letter to Editor on, "Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)"
    Jeyaraj, Gnanaprakash
    ORAL ONCOLOGY, 2025, 163
12345